VK

Vivek Kumar

Active Director Director DIN 10381542
DIN 10381542 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Vivek Kumar

Data last updated:

Vivek Kumar is a Director at Eqqus Biotech Private Limited (since 2023). The company operates in Paper. Eqqus Biotech Private Limited reported revenue of ₹33.5 Lakh (FY 2025).

DIN 10381542
Primary Designation Director
Industry Paper
First Appointment 06 Nov 2023
Oldest Company Age 2 yrs
Largest company Eqqus Biotech Private Limited · ₹33.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eqqus Biotech Private Limited U21000BR2023PTC066008
Director06 Nov 20232023₹33.5 Lakh (FY 2025)Active

Board colleagues of Vivek Kumar

NameDINCompanyDesignation
Rakesh Kumar08313255Eqqus Biotech Private LimitedIndividual Subscriber

Directorship timeline

Open interactive timeline →
Eqqus Biotech Private Limited
Premium access

Shareholding and investment profile for Vivek Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Kumar

Vivek Kumar currently holds 1 directorship: Eqqus Biotech Private Limited (Director, since 06 Nov 2023, revenue ₹33.5 Lakh (FY 2025)).

Vivek Kumar was first appointed on 06 Nov 2023 as Director at Eqqus Biotech Private Limited.

The current boards of Vivek Kumar's companies include Rakesh Kumar (Eqqus Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available